share_log

Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties

Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties

Aclaris Therapeutics宣布与Sun Pharma就Deuruxolitinib的权利达成独家专利许可协议;协议包括1500万美元的预付款,外加里程碑和特许权使用费
Benzinga ·  2023/12/05 16:02

Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties

Aclaris Therapeutics宣布与Sun Pharma就Deuruxolitinib的权利达成独家专利许可协议;协议包括1500万美元的预付款,外加里程碑和特许权使用费

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发